Cerecin's Corporate Minority Round

Cerecin raised a round of funding on July 18, 2012. Investors include Nestle.

Cerecin, fka Accera, is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative …

Articles about Cerecin's Corporate Minority Round: